RELAXO FOOTWEARS LTD.-$ - 530517 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Newspaper Advertisement for Audited Financial Results for the quarter 4 and financial year ended on March 31, 202311-05-2023
11-05-2023
RELAXO FOOTWEARS LTD.-$ - 530517 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Intimation of Schedule of Investors call under regulation 30 of SEBI (Listing Obligation and Disclosure Requirements) Regulations, 201510-05-2023
RELAXO FOOTWEARS LTD.-$ - 530517 - Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS
Intimation for Grant of 16,800 options pursuant to RFL ESOP Plan 201410-05-2023
Q4FY23 Quarterly & FY23 Annual Result Announced for Relaxo Footwears Ltd.
Relaxo Footwears announced Q4FY23 & FY23 results: Q4FY23: Revenue at Rs 765 crore in Q4FY23 as against revenue of Rs 698 crore in Q4FY22, a growth of 10% YoY EBITDA is at Rs 118 crore in Q4FY23 as compared to Rs 111 crore in Q4FY22 EBITDA margin stood at 15.4% in Q4FY23 as against 15.9% in Q4FY22 Profit after tax at Rs 63 crore in Q4FY23. PAT margin stood at 8.3% as compared to 9.0% in Q4FY22. Better operating margin aided in the improvement of PAT Margin by 386 bps on a QoQ basis. FY23: Revenue at Rs 2,783 crore in FY23 as compared to Rs 2,653 crore in FY22, up by 5% EBITDA at Rs 336 crore in FY23 as compared to Rs 416 crore in FY22. EBITDA Margin stood at 12.1% in FY23, as compared to 15.7% in FY22 Profit after tax at Rs 154 crore in FY23 as compared to Rs 233 crore in FY22. PAT margin stood at 5.6% in FY23 as compared to 8.8% in FY22 Commenting on the results and performance, Ramesh Kumar Dua, Managing Director, said: “We are pleased with the performance of your company in Q4FY23, which was supported by substantial business growth across all segments as compared to previous quarters. Despite the challenging environment last year, our strong team responded effectively, and we remain committed to maintaining the high standards of excellence that have made us successful. Our price correction efforts have resulted in good momentum as we continue to recover our market share in all major segments without relying on discounts or offers. Our strong brand identity, robust distribution channels, and effective marketing strategies have facilitated our growth across categories, backed by our strong manufacturing facilities. Raw material prices have stabilized, enabling us to offer competitive prices in the market. Additionally, the majority of the high-cost old inventory has been liquidated & now new inventory with lower costs has started going to the markets, leading to improved margins this quarter. We are now a debt-free company with robust cash flow from operations, due to our strong working capital management. We believe these factors will help us to maintain our growth trajectory in the coming quarters. Looking ahead, we have a positive outlook for the industry and believe that our company is well-positioned to capitalize on opportunities arising due to the increased per capita footwear consumption and growing share of the organized market. We are confident that our efforts will continue to yield positive results.” Result PDF10-05-2023
RELAXO FOOTWEARS LTD.-$ - 530517 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Press Release on Audited Financial Results for the quarter and year ended on March 31, 202310-05-2023
RELAXO FOOTWEARS LTD.-$ - 530517 - Outcome Of Board Meeting Held On May 10, 2023 - Audited Financial Results For The Quarter And Year Ended On March 31, 2023 And Intimation Of Final Dividend
Outcome of Board Meeting held on May 10, 2023 - Audited Financial Results for the quarter and year ended on March 31, 2023 and Intimation of Final Dividend10-05-2023
RELAXO FOOTWEARS LTD.-$ - 530517 - Corporate Action-Board approves Dividend
Pursuant to Regulation 30 read with Schedule Ill of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the Board of Directors in their meeting held on today, i.e. May 10, 2023, recommended final dividend at the rate of INR 2.50/- per equity share (i.e. 250%) of face value of INR 1/- (Rupees One only) each for the year ended March 31, 2023, for the approval of members in the forthcoming Annual General Meeting (AGM) of the Company.10-05-2023
RELAXO FOOTWEARS LTD.-$ - 530517 - Board Meeting Outcome for Outcome Of Board Meeting Held On May 10, 2023 - Audited Financial Results For The Quarter And Year Ended On March 31, 2023 And Intimation Of Final Dividend
Outcome of Board Meeting held on May 10, 2023 - Audited Financial Results for the quarter and year ended on March 31, 2023 and Intimation of Final Dividend10-05-2023
RELAXO FOOTWEARS LTD.-$ - 530517 - Board Meeting Intimation for Audited Financial Results & Final Dividend
RELAXO FOOTWEARS LTD.-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/05/2023 ,inter alia, to consider and approve 1. To consider, review, approve and take on record Audited Financial Results for the quarter and year ended on March 31, 2023. 2. To consider and recommend final dividend, if any, for the Financial Year ended on March 31, 2023, for the approval of shareholders, at the ensuing Annual General meeting.02-05-2023